FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth
COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach
THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
